Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $0.46.

  • BIO-TECHNE's EPS (Weighted Average and Diluted) rose 14.29% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.49, marking a year-over-year decrease of 48.42%. This contributed to the annual value of $0.46 for FY2025, which is 56.19% down from last year.
  • As of FY2025, BIO-TECHNE's EPS (Weighted Average and Diluted) stood at $0.46, which was down 56.19% from $1.05 recorded in FY2024.
  • Over the past 5 years, BIO-TECHNE's EPS (Weighted Average and Diluted) peaked at $1.76 during FY2023, and registered a low of $0.46 during FY2025.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $1.05 (2024), whereas its average is $1.09.
  • As far as peak fluctuations go, BIO-TECHNE's EPS (Weighted Average and Diluted) crashed by 85.05% in 2021, and later surged by 90.80% in 2022.
  • Yearly analysis of 5 years shows BIO-TECHNE's EPS (Weighted Average and Diluted) stood at $0.87 in 2021, then skyrocketed by 90.80% to $1.66 in 2022, then grew by 6.02% to $1.76 in 2023, then plummeted by 40.34% to $1.05 in 2024, then plummeted by 56.19% to $0.46 in 2025.